• Time for Pharma to Face Social Media Fears?

    Bio-IT World | Guest Commentary | As tools like Facebook and Twitter become a permanent reality of human interaction, savvy businesses are standing up and taking notice. Yet the pharmaceutical industry remains apprehensive about jumping on the social media bandwagon.  

     

    Aug 1, 2011

  • Federal Court Rules in Favor of Gene Patents

    New York Times | The Court of Appeals for the Federal Circuit ruled on Friday that genes can be patented, overturning a lower court decision.

    Jul 31, 2011

  • Phenomic Outcome Research with Patient-Volunteers

    Bio-IT World Video | At the Bio-IT World Expo, Ben Heywood, co-founder and CEO of PatientsLikeMe, quoted Catherine the Great: “A great wind is blowing and that gives you either imagination or a headache.”

    Jul 29, 2011

  • Team Tracks E. coli's Evolution with PacBio Sequencing

    HHMI | An international team of researchers seeking to understand the recent particularly virulent E. coli infections have compared the bacteria's genome to that of 11 related strains of E. coli using Pacific Biosciences sequencing technology.

    Jul 27, 2011

  • Balancing Race in Personal Genomics

    Wired | Yesterday 23andMe launched the Roots into the Future project, an attempt to add race balance to personal genomics.

    Jul 27, 2011

  • What Biotech Can Learn from Gamers

    Bio-IT World Video | Martin Leach opened his talk at the Bio-IT World Expo with, "And now for something completely different..."

    Jul 27, 2011

  • BGI Researchers Publish New Structural Variation Pipeline, Push for De Novo Assembly

    Bio-IT World | BGI researchers just released the single-nucleotide resolution structural variations (SVs) of an Asian and African genome discovered de novo genome assembly. The research was published online on Tuesday in Nature Biotechnology.

    Jul 26, 2011

  • Dell Offers Cloud Services in Singapore

    Bio-IT World | SINGAPORE—Dell announced the launch of the Dell Solution Center (DSC) in Singapore, today, one of twelve DSCs launching globally in 2011, and the only site in South Asia.

    Jul 22, 2011

  • Oxford Nanopore Opens Cambridge Bioinformatics Hub

    Business Weekly | Oxford Nanopore has opened a new office in Cambridge, UK, to help recruit "the best informaticians," suggesting it may be hoping to lure some talent from the European Bioinformatics Institute and other premier organizations in the region.

    Jul 21, 2011

  • A Sequencing Squabble over Ion Torrent’s Stanford Licenses

    Bio-IT World | As Ion Torrent publishes details of its destop sequencing technology in Nature this week, charges continue to fly over the intellectual credit for some of the key technology that Ion Torrent exclusively licensed from Stanford University’s Office of Technology Licensing.  

    Jul 20, 2011

  • Drug Discovery with Computational Chemistry

     Technology Review | Nimbus Discovery is using computational chemistry to drive the drug discovery process.  

    Jul 19, 2011

  • Ignite Institute Finds a Match at Fox Chase

    Bio-IT World | Following the demise of plans to locate the Ignite Institute for Individualized Health in Northern Virginia, the institute has found a new home as part of a three-way partnership with Life Technologies at the Fox Chase Cancer Center in Philadelphia.  

    Jul 18, 2011

  • Knome Assists Canadian Team Identify Parkinson’s Disease Gene

    Bio-IT World | An international consortium led by researchers at the University of British Columbia (UBC) in Canada, with a major assist from the genome analysis company Knome, have used exome sequencing to identify the sixth known inherited gene defect causing Parkinson’s disease (PD).  

    Jul 14, 2011

  • Updated Accelrys Discovery Studio Targets Protein Aggregation

    Bio-IT World | With the latest release of its flagship modeling and simulation software, Discovery Studio, Accelrys is hoping to boost scientific collaboration and efficiency, as well as address a major challenge in the development of biotherapeutics. 

    Jul 13, 2011

  • “Ending Diagnostic Odysseys”: A Bio-IT World Podcast

    Bio-IT World | In this exclusive podcast, recorded at the Copenhagenomics conference last month, Liz Worthey (Medical College Wisconsin) discusses the widely publicized case of the clinical genome sequencing of Nicholas Volker, the challenges of data analysis, and how that experience has provided the foundation for ongoing clinical genome sequencing efforts. 

    Jul 11, 2011

  • CLC bio Expands Software Trial for Mini Next-Gen Sequencers

    Bio-IT World | Anticipating a flood of new customers for three dynamic new bench top next-gen sequencing instruments, Danish software company CLC bio is extending the trial period for its flagship NGS software product to six months.   

    Jul 7, 2011

  • BGI Announces Cloud Genome Assembly Service

    Bio-IT World | SHENZHEN, CHINA—At the BGI Bioinformatics Software Release Conference yesterday, researchers announced two new Cloud-based software-as-a-service offerings for next-gen data analysis. Hecate and Gaea (named for Greek gods) are “flexible computing” solutions for do novo assembly and genome resequencing. 

     

    Jul 6, 2011

  • Ashburner, Troyanskaya Win ISCB Computational Biology Awards

    PLoS Computational Biology | The International Society for Computational Biology has given its 2011 senior scientist award to British geneticist Michael Ashburner (University of Cambridge, UK), while the Overton Prize for a young scientist making a significant impact in the field goes to Princeton's Olga Troyanskaya.

    Jul 5, 2011

  • Navigenics Settles Junk DNA Lawsuit with Genetic Technologies

    Herald Sun | "Genetic Technologies has brought another large US company to its knees in a drive to stamp its ownership on a type of DNA testing" is how Melbourne's Herald Sun portrays the news of another patent settlement engineered by the Australian firm, this time with personal genomics company Navigenics.

    Jun 29, 2011

  • Lilly Pledges Millions to Biotech

    Bloomberg | Yesterday Eli Lilly announced plans to make a mulitmillion-dollar investment in its biotech business, but declined to give a specific number.

    Jun 29, 2011